Chester County News and Community Website
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) announced the distribution of quality improvement research grants to advance care for patients with Chronic Lymphocytic Leukemia …
NCCN Awards New Grants to Improve Care for CLL/SLL Patients Read More
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) is set to present three pivotal clinical studies on its Barrigel™ rectal spacer at the American Society for Radiation Oncology (ASTRO) Annual Meeting, …
Teleflex to Showcase Barrigel Rectal Spacer Studies at ASTRO 2024 Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently unveiled a draft guidance designed to enhance multiregional clinical trials (MRCTs) in oncology, aimed at improving data relevance for …
FDA Issues Draft Guidance on Multiregional Clinical Trials in Oncology Read More
NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (Nasdaq: AVBP) has announced encouraging interim results from its global Phase 1b FURTHER trial, presented at the prestigious IASCLC 2024 World Conference on Lung …
ArriVent BioPharma Unveils Promising Phase 1b Data for Firmonertinib in Treating NSCLC Read More
WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) has revealed groundbreaking clinical data on its novel therapeutic agent, PRT3789, at the European Society of Medical Oncology (ESMO) Congress 2024 in Barcelona. …
Prelude Therapeutics Unveils Promising Data on PRT3789 at ESMO Congress 2024 Read More
PLYMOUTH MEETING, PA — In the constantly evolving field of medical science, staying updated with the latest advancements is crucial, and the National Comprehensive Cancer Network® (NCCN®) is leading the …
NCCN Announces Game-Changing Updates to Cancer Treatment Guidelines Read More
PHILADELPHIA, PA — Carisma Therapeutics Inc., a biopharmaceutical company specializing in engineered macrophage-based therapies, has announced the nomination of its first lead candidate under a strategic collaboration with Moderna Inc. …
Carisma Therapeutics and Moderna Progress with Groundbreaking Oncology Collaboration Read More